Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowHematopoietic Stem CellsBone Marrow TransplantationBone Marrow CellsLeukapheresisGranulocyte Colony-Stimulating FactorStem CellsTransplantation, HomologousBlood Component RemovalTransplantation ConditioningAntigens, CD34Hematologic NeoplasmsGraft vs Host DiseaseBlood CellsMelphalanHematopoiesisCyclophosphamideCombined Modality TherapyBone and BonesGraft SurvivalMultiple MyelomaStem Cell TransplantationBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountCord Blood Stem Cell TransplantationTreatment OutcomeCell DifferentiationBone Marrow PurgingLymphoma, Non-HodgkinLeukemiaTissue DonorsEtoposideAntineoplastic Agents, AlkylatingMyeloablative AgonistsPhosphoramidesTransplantation ChimeraThiotepaHemangioblastsRecurrenceWhole-Body IrradiationRemission InductionCells, CulturedHistocompatibilityColony-Forming Units AssayFlow CytometryPlatelet CountCell SeparationMice, Inbred C57BLHistocompatibility TestingIfosfamideBlood DonorsT-LymphocytesAnemia, AplasticTime FactorsEmbryonic Stem CellsImmunophenotypingCytarabineHematopoietic SystemDisease-Free SurvivalLeukocytes, MononuclearLeukocyte CountInfectionAdult Stem CellsRecombinant ProteinsTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone RemodelingVidarabinePOEMS SyndromeVincristineRetrospective StudiesSalvage TherapyImmunomagnetic SeparationImmunosuppressive AgentsBone Marrow ExaminationSurvival RateHodgkin DiseaseStem Cell FactorAntigens, CDLymphomaSurvival AnalysisBone Marrow NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsCarmustineMyelodysplastic SyndromesSpleenGranulocytesCell LineHematologic DiseasesLymphocyte DepletionProchlorperazinePlatelet TransfusionPluripotent Stem Cells